Kaplan Fox Encourages Gildan Activewear Inc. (NYSE: GIL) Investors to Contact the Firm Before the Deadline on December 14, 2026

Gildan shares fell $11.63, or 18.7%, to $50.34 on June 16, 2026, after short seller Jehoshaphat Research alleged channel stuffing and said about $500 million of revenue had been pulled forward. A securities class action filed on behalf of investors who acquired shares from February 19, 2025, through June 15, 2026, alleges inadequate internal controls and revenue inflation; these are allegations, not established findings. The lead-plaintiff deadline is December 14, 2026.

Analysis

This filing adds legal and disclosure overhang, not independent evidence that the short seller’s accounting allegations are true. The sharp June repricing may already reflect much of the immediate claim risk; the new information is a potential path to discovery and increased scrutiny, with the December 14 lead-plaintiff deadline a procedural rather than fundamental catalyst. The key economic risk is asymmetric if the allegations are substantiated: revenue pulled forward would create a later-period sales hole, while elevated receivables or returns could also weaken cash conversion and force revisions to prior-period results. Those outcomes could pressure both earnings estimates and the valuation investors assign to reporting credibility. For the next 1–3 months, focus on company responses, court developments, and the next filings/results; over 6–18 months, any verified control weakness or restatement would matter more than the lawsuit’s existence. If retailers respond by diversifying orders, apparel-basics competitors such as Hanesbrands or Fruit of the Loom could benefit, but there is no evidence here of customer switching. The contrarian point: headline litigation is often a weak standalone signal after a large event-day selloff, but the underlying receivables and channel-inventory questions are testable and could make downside persist if subsequent disclosures fail to resolve them.

Key Decisions for Investors

• Do not add to a GIL short solely on this law-firm announcement. Treat it as an overhang and wait for verifiable evidence; the complaint repeats allegations tied to a short-position report.
• For existing GIL exposure, review the next reported revenue against receivables, days sales outstanding, cash from operations, returns/allowances, and any disclosed channel inventory. Escalate concern if receivables continue to outpace sales or cash conversion deteriorates; improvement would weaken the bear case.
• Use the December 14, 2026 lead-plaintiff deadline as a monitoring date, not a thesis catalyst. More material catalysts are court rulings on the complaint, company disclosures, auditor/control findings, or revisions to guidance and prior results.
• Avoid a peer pair trade until there is evidence of customer reallocation. Falsify the bearish fundamental thesis if Gildan’s subsequent filings show normalizing receivables and cash conversion without revenue or guidance revisions; strengthen it if a restatement, control deficiency, or sustained sales shortfall emerges.